India to Egypt: Mercaptopurine Export Trade Route

The India to Egypt Mercaptopurine corridor is one of India's established pharmaceutical export routes, with 6 shipments documented worth a combined $13.6K USD. The route is dominated by AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED, which alone accounts for roughly 75% of all export value, reflecting the consolidated nature of India's mercaptopurine manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $2.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with mercaptopurine's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 27.9%, placing it at rank #4 among India's top mercaptopurine export destinations globally.

On the import side, key buyers of Indian mercaptopurine in Egypt include ROYAL PHARMA CO., ROYAL PHARMA, ROYAL MEDICAL AMREYA PUBLIC FREE and 2 others. ROYAL PHARMA CO. is the single largest importer with 2 shipments valued at $6.4K USD.

India's mercaptopurine exports to Egypt are driven primarily by a handful of large-scale manufacturers. AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Egypt benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED, AL ROYAL PHARMACEUTICAL PRIVATE LIMITED, AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED — together account for 98% of total trade value on this route. The average shipment value of $2.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as mercaptopurine 50mg tab 6-mp tab bn-cwa1032,md-04/24,ed-03/261110 pcs,bn-cwa1039,md-04/24,ed-03/263560 pcs as per inv. and mercaptopurine 50mg tab b no bvy1137 cwz1006 m dt 12 22 01 23 e dt 11 24 12 24, suggesting that buyers in Egypt tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ROYAL PHARMA CO. is the largest importer with 2 shipments worth $6.4K USD — representing 47% of all mercaptopurine imports from India on this route.